Side-by-side comparison of AI visibility scores, market position, and capabilities
Diageo-owned (DEO) world's best-selling vodka in 130+ countries with 60+ flavor variants and Smirnoff Ice RTD; facing tequila category pressure while extending into hard seltzer.
Smirnoff is the world's best-selling vodka brand, owned by Diageo (LON: DGE / NYSE: DEO) — offering a portfolio of original, flavored, and ready-to-drink vodka products that span from the entry-level Smirnoff No. 21 triple-distilled vodka to flavored extensions (Smirnoff Raspberry, Watermelon, Green Apple, 60+ flavor variants) to Smirnoff Ice flavored malt beverages and Smirnoff Seltzer hard seltzer. Smirnoff is one of Diageo's largest and most globally distributed brands, reaching 130+ countries.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.